title: Eliminating residual iPS cells for safety in clinical application.
authors.affiliation: Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, 565-0871, Japan.
authors.forename: Shigeo
authors.initials: S
authors.lastname: Masuda
authors.forename: Shigeru
authors.initials: S
authors.lastname: Miyagawa
authors.forename: Satsuki
authors.initials: S
authors.lastname: Fukushima
authors.forename: Nagako
authors.initials: N
authors.lastname: Sougawa
authors.forename: Kaori
authors.initials: K
authors.lastname: Okimoto
authors.forename: Chika
authors.initials: C
authors.lastname: Tada
authors.forename: Atsuhiro
authors.initials: A
authors.lastname: Saito
authors.forename: Yoshiki
authors.initials: Y
authors.lastname: Sawa
mesh_terms: D000818:Animals; D002454:Cell Differentiation; D002986:Clinical Trials as Topic; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000166:cytology*; D051379:Mice; D033581:Stem Cell Transplantation; D013724:Teratoma / Q000473:pathology